Literature DB >> 26147866

Using machine learning to examine medication adherence thresholds and risk of hospitalization.

Wei-Hsuan Lo-Ciganic1, Julie M Donohue, Joshua M Thorpe, Subashan Perera, Carolyn T Thorpe, Zachary A Marcum, Walid F Gellad.   

Abstract

BACKGROUND: Quality improvement efforts are frequently tied to patients achieving ≥80% medication adherence. However, there is little empirical evidence that this threshold optimally predicts important health outcomes.
OBJECTIVE: To apply machine learning to examine how adherence to oral hypoglycemic medications is associated with avoidance of hospitalizations, and to identify adherence thresholds for optimal discrimination of hospitalization risk.
METHODS: A retrospective cohort study of 33,130 non-dual-eligible Medicaid enrollees with type 2 diabetes. We randomly selected 90% of the cohort (training sample) to develop the prediction algorithm and used the remaining (testing sample) for validation. We applied random survival forests to identify predictors for hospitalization and fit survival trees to empirically derive adherence thresholds that best discriminate hospitalization risk, using the proportion of days covered (PDC). OUTCOMES: Time to first all-cause and diabetes-related hospitalization.
RESULTS: The training and testing samples had similar characteristics (mean age, 48 y; 67% female; mean PDC=0.65). We identified 8 important predictors of all-cause hospitalizations (rank in order): prior hospitalizations/emergency department visit, number of prescriptions, diabetes complications, insulin use, PDC, number of prescribers, Elixhauser index, and eligibility category. The adherence thresholds most discriminating for risk of all-cause hospitalization varied from 46% to 94% according to patient health and medication complexity. PDC was not predictive of hospitalizations in the healthiest or most complex patient subgroups.
CONCLUSIONS: Adherence thresholds most discriminating of hospitalization risk were not uniformly 80%. Machine-learning approaches may be valuable to identify appropriate patient-specific adherence thresholds for measuring quality of care and targeting nonadherent patients for intervention.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26147866      PMCID: PMC4503478          DOI: 10.1097/MLR.0000000000000394

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  40 in total

Review 1.  The language of medication-taking.

Authors:  J F Steiner; M A Earnest
Journal:  Ann Intern Med       Date:  2000-06-06       Impact factor: 25.391

Review 2.  Adherence to medication.

Authors:  Lars Osterberg; Terrence Blaschke
Journal:  N Engl J Med       Date:  2005-08-04       Impact factor: 91.245

3.  Identifying important risk factors for survival in patient with systolic heart failure using random survival forests.

Authors:  Eileen Hsich; Eiran Z Gorodeski; Eugene H Blackstone; Hemant Ishwaran; Michael S Lauer
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-11-23

4.  Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.

Authors:  Joseph Menzin; Jonathan R Korn; Joseph Cohen; Francis Lobo; Bin Zhang; Mark Friedman; Peter J Neumann
Journal:  J Manag Care Pharm       Date:  2010-05

5.  Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction.

Authors:  Jeppe N Rasmussen; Alice Chong; David A Alter
Journal:  JAMA       Date:  2007-01-10       Impact factor: 56.272

6.  Impact of medication adherence on hospitalization risk and healthcare cost.

Authors:  Michael C Sokol; Kimberly A McGuigan; Robert R Verbrugge; Robert S Epstein
Journal:  Med Care       Date:  2005-06       Impact factor: 2.983

7.  The implications of therapeutic complexity on adherence to cardiovascular medications.

Authors:  Niteesh K Choudhry; Michael A Fischer; Jerry Avorn; Joshua N Liberman; Sebastian Schneeweiss; Juliana Pakes; Troyen A Brennan; William H Shrank
Journal:  Arch Intern Med       Date:  2011-05-09

8.  Development and validation of a quantitative real-time polymerase chain reaction classifier for lung cancer prognosis.

Authors:  Guoan Chen; Sinae Kim; Jeremy M G Taylor; Zhuwen Wang; Oliver Lee; Nithya Ramnath; Rishindra M Reddy; Jules Lin; Andrew C Chang; Mark B Orringer; David G Beer
Journal:  J Thorac Oncol       Date:  2011-09       Impact factor: 15.609

9.  Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus.

Authors:  P Michael Ho; John S Rumsfeld; Frederick A Masoudi; David L McClure; Mary E Plomondon; John F Steiner; David J Magid
Journal:  Arch Intern Med       Date:  2006-09-25

10.  Screening large-scale association study data: exploiting interactions using random forests.

Authors:  Kathryn L Lunetta; L Brooke Hayward; Jonathan Segal; Paul Van Eerdewegh
Journal:  BMC Genet       Date:  2004-12-10       Impact factor: 2.797

View more
  24 in total

1.  Effectiveness of Targeted Insulin-Adherence Interventions for Glycemic Control Using Predictive Analytics Among Patients With Type 2 Diabetes: A Randomized Clinical Trial.

Authors:  Julie C Lauffenburger; Jennifer Lewey; Saira Jan; Sagar Makanji; Christina A Ferro; Alexis A Krumme; Jessica Lee; Roya Ghazinouri; Nancy Haff; Niteesh K Choudhry
Journal:  JAMA Netw Open       Date:  2019-03-01

2.  A Machine-Learning Based Approach for Predicting Older Adults' Adherence to Technology-Based Cognitive Training.

Authors:  Zhe He; Shubo Tian; Ankita Singh; Shayok Chakraborty; Shenghao Zhang; Mia Liza A Lustria; Neil Charness; Nelson A Roque; Erin R Harrell; Walter R Boot
Journal:  Inf Process Manag       Date:  2022-07-21       Impact factor: 7.466

3.  Use of machine learning to identify patients at risk of sub-optimal adherence: study based on real-world data from 10,929 children using a connected auto-injector device.

Authors:  Amalia Spataru; Paula van Dommelen; Lilian Arnaud; Quentin Le Masne; Silvia Quarteroni; Ekaterina Koledova
Journal:  BMC Med Inform Decis Mak       Date:  2022-07-06       Impact factor: 3.298

4.  Artificial Intelligence in Pharmacoepidemiology: A Systematic Review. Part 1-Overview of Knowledge Discovery Techniques in Artificial Intelligence.

Authors:  Maurizio Sessa; Abdul Rauf Khan; David Liang; Morten Andersen; Murat Kulahci
Journal:  Front Pharmacol       Date:  2020-07-16       Impact factor: 5.810

5.  Adherence to Anticoagulation and Risk of Stroke Among Medicare Beneficiaries Newly Diagnosed with Atrial Fibrillation.

Authors:  Inmaculada Hernandez; Meiqi He; Maria M Brooks; Samir Saba; Walid F Gellad
Journal:  Am J Cardiovasc Drugs       Date:  2020-04       Impact factor: 3.571

6.  Measuring the multiple domains of medication nonadherence: findings from a Delphi survey of adherence experts.

Authors:  Ian M Kronish; Carolyn T Thorpe; Corrine I Voils
Journal:  Transl Behav Med       Date:  2021-02-11       Impact factor: 3.626

Review 7.  Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic literature review.

Authors:  Marc Evans; Susanne Engberg; Mads Faurby; João Diogo Da Rocha Fernandes; Pollyanna Hudson; William Polonsky
Journal:  Diabetes Obes Metab       Date:  2021-12-09       Impact factor: 6.408

8.  Are Randomized Controlled Trials the (G)old Standard? From Clinical Intelligence to Prescriptive Analytics.

Authors:  Sven Van Poucke; Michiel Thomeer; John Heath; Milan Vukicevic
Journal:  J Med Internet Res       Date:  2016-07-06       Impact factor: 5.428

9.  Challenges associated with insulin therapy progression among patients with type 2 diabetes: Latin American MOSAIc study baseline data.

Authors:  Bruno Linetzky; Brad Curtis; Gustavo Frechtel; Renan Montenegro; Miguel Escalante Pulido; Oded Stempa; Janaina Martins de Lana; Juan José Gagliardino
Journal:  Diabetol Metab Syndr       Date:  2016-07-22       Impact factor: 3.320

10.  Adherence to Antipsychotic Medication and Criminal Recidivism in a Canadian Provincial Offender Population.

Authors:  Stefanie N Rezansoff; Akm Moniruzzaman; Seena Fazel; Lawrence McCandless; Julian M Somers
Journal:  Schizophr Bull       Date:  2017-09-01       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.